|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $3,217 and $2,750, respectively | |||||||||||||||||
| Inventories | |||||||||||||||||
| Derivative assets | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Property, plant and equipment, net | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||
| Other long-term assets | |||||||||||||||||
| Total Assets | |||||||||||||||||
| LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) | |||||||||||||||||
| Current maturities of long-term debt | |||||||||||||||||
| Short-term debt | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Supply chain finance program | |||||||||||||||||
| Derivative liabilities | |||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Long-term debt, net | |||||||||||||||||
| Convertible notes payable - related party, net | |||||||||||||||||
| Deferred income taxes | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Warrant liabilities | |||||||||||||||||
| Other long-term liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Series A Convertible Preferred Shares, $0.01 par value, 24,000 shares authorized, 23,511 shares and 23,511 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively, $11.50 liquidation value | |||||||||||||||||
| Series A Redeemable Common Equivalent Preferred Shares | |||||||||||||||||
| Shareholders' Equity (Deficit) | |||||||||||||||||
| Common stock, $0.01 par value, 300,000 shares authorized, 97,627 shares and 96,866 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Additional paid-in-capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||
| Total shareholders' equity | |||||||||||||||||
| Total shareholders' equity (deficit) | |||||||||||||||||
| Total Liabilities, Convertible Preferred Shares and Shareholders' Equity (Deficit) | |||||||||||||||||
Loading...
